Slideshow

10 Factors to Consider When Assessing PTSD

Author(s):

Ralph J. Koek, MD

The author addresses some of the complexities in assessing and managing treatment-resistant PTSD.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
PTSD
Gus Alva, MD
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
Related Content
PTSD diagnosis
August 6th 2025

PTSD In Review: Treatment Insights

Jessica Walters
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
August 6th 2025

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
thumbs down
August 6th 2025

FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD

Leah Kuntz
Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety
August 6th 2025

Anne Marie Albano, PhD: A Conversation on the Spectrum of Anxiety

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
PTSD
August 6th 2025

Rexulti in Combination With Sertraline for PTSD: Upcoming FDA Advisory Committee Discussion

Leah Kuntz
Lone Star Elegy
August 6th 2025

Lone Star Elegy

Frank A. Clark, MD
© 2025 MJH Life Sciences

All rights reserved.